Tag Archive for: Alfasigma

VirusCDC.gov
Herpes Virus

Munich’s Innovative Molecules signs €125M partnership with Alfasigma to advance HSV encephalitis antiviral

Munich-based Innovative Molecules steps into the spotlight with a partnership with Italy’s Alfasigma. The deal brings fresh capital and a global licence for adibelivir, a next-generation antiviral targeting the ultra-rare, life-threatening Herpes Simplex Virus (HSV) encephalitis.

Read more
Alfasigma manufacturing plant. © N. Biddau/Alfasigma SpA
Collaboration

Alfasigma SpA signs €170m deal with Galapagos NV

Following its announcement from Oktober 2023 to take over the filgotinib business from Galapagos NV, Bologna-based Alfasigma SpA has signed the €170m deal.

Read more